TEJAS PATEL MD, FACP, FASN

IMRes @UICDOM; @OSUPublichealth; Hypertension+Neph @BWHKidney @MGHKidneys ‘09; @Chicagobooth; Let’s make things better! #EPluribusUnum

[American Society of Nephrology @ASNKidney]

🗣️The wait is over. The #KidneyWk 2026 program is here.

Explore 17 Learning Pathways featuring 140+ educational sessions, 7 Early Programs, 600+ expert faculty, 4,000+ abstracts, and more. Registration and housing open Wednesday, June 24, at 10:00 a.m. EDT.

👉https://t.co/sy51srGGn5

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@GlassockJ @ASNKidney
👍👏

[American Society of Nephrology @ASNKidney]

What lessons from the past can help shape the future of glomerular disease?

In a new episode of Convergence, Richard Glassock, MD, traces decades of progress in glomerular disease and shares his perspective on the future of biomarkers, clinical trials, and prevention.

Listen now: https://t.co/DFqxgpClJh

[NEJM @NEJM]

Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) https://t.co/y4G27hfORg

#ASCO26 | @ASCO

[Eric Topol @EricTopol]

Another major advance vs cancer! @ASCO #ASCO26
Personalized neoantigen mRNA vaccine 5 year follow-up vs metastatic melanoma reduced recurrence and death by 49% (on top of Keytruda)
https://t.co/NadITTYIT2

[UT Southwestern Internal Medicine @UTSWInternalMed]

Join us in congratulating @samirparikhmd, Professor and Chief of the Division of Nephrology, on being appointed Chair of Internal Medicine! @UTSWMedCenter https://t.co/aQEfMk3IQ4

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@EvidenceOpen @CedarsSinai Amazing! This is a giant leap. Exciting times ahead.

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@EricTopol Vitamin D takes the prize for much ado about nothing…amount of time, money, human capital spent by researchers and by people on this unregulated over the counter product is astonishing.

[Fouad Chebib, MD, FASN @fouadchebib]

Excited to launch the inaugural Mayo Clinic Nephrogenetics course.

Amazing energy, outstanding discussions, and an incredible group of national and international experts coming together to advance precision nephrology and genetics in clinical practice.

This is just the beginning.

#Nephrology #Nephrogenetics #Genetics #PrecisionMedicine #MayoClinic #KidneyDisease

https://t.co/hKmRGsV0d6

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

Curiosity rather than feeling stupid is the key to scientific advancement…stay humble and hungry

The Astounding Discovery That Could Link Eastern and Western Medicine https://t.co/hXOnATcPYa via @NYTimes

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@priti899 @kdjhaveri @myadla @arvindcanchi @thisis_drgsp @BeheraVineet @valerie_luyckx @silvishah @SwarnalathaGud2 @DivyaveerSSNeph @Kavitasv20 Big deal indeed! Congratulations!!!

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

Princeton Changes Its 133-Year-Old Honor Code Over AI Cheating Fears
#AI https://t.co/McsTXhK1Y9

[Sanjeev Sethi @SethiRenalPath]

We initially reported Semaphorin 3B (SEMA3B) as a target antigen in pediatric membranous nephropathy (MN)

However, we are also seeing SEMA3B in adult MN.

Unique features of adult SEMA3B MN: Most patients are middle aged adult females (86%), almost half had a history of pregnancy/miscarriage.

I wonder if the pediatric SEMA3B MN and adult female/pregnancy associated SEMA3B MN are somehow related.

https://t.co/u8Cu2AcUHC

[Eric Topol @EricTopol]

A good, new review of orthostatic hypotension, POTS @JAMAInternalMed https://t.co/hKCdwtOFIY

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

When can we expect #APOL1 channel inhibitors get @US_FDA approval? @VertexPharma #amkd @ASNKidney @KidneyFund

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

Interesting physiology study

Efficacy of Tonlamarsen in Patients with Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial | ⁦@JACCJournals⁩ #hypertension #angiotensinogen https://t.co/4be2L1n9Wv

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

Debate on a phenotype that is poorly measured and managed in clinical practice. 13 minutes to measure BP is not a practical recommendation. #hypertension

@NEJM Blood-Pressure Targets in Hypertension Management | New England Journal of Medicine https://t.co/2jxZNXmplO

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

Every line is a pouch line.

@NEJM

Number Needed to Treat | New England Journal of Medicine https://t.co/cwX5KppHQW

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@alt_w_v_g This. Is. So. Amazing. Pure gold!

[TEJAS PATEL MD, FACP, FASN @GenNextMD]

@GlassockJ @GrahamAbra Longing for a time when we don’t have to go through prior authorization on individual drugs but rather bundle them (as done by onc) - deliver right care in time sensitive manner.

[Anupam Agarwal @anupamuab]

Three years ago today, Dawn Bulgarella and I were appointed by the UA System Board of Trustees. Grateful to serve alongside Dawn and honored to help advance the @uabmedicine and @UABHeersink shared mission and vision - looking forward to the work ahead.